CERO THERAPEUTICS HOLDINGS, INC.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Phone
650-407-2376
Fiscal Year End
1231
EIN
871088814
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 15, 2026 | View on SEC |
| 8-K Current report of material events | April 14, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 11, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 4, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
Annual Reports
10-K
April 15, 2026
- Focused on developing CER-1236, a novel immune-based cancer treatment.
- Advancing proprietary CER-T cell technology toward human clinical trials.
Related Companies
Companies in the same industry (SIC: 2836)
Aura Biosciences, Inc.
AURA
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Abpro Holdings, Inc.
ABPO
Biological Products, (No Diagnostic Substances)
BioCardia, Inc.
BCDA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.